Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SEC Rule changes

But many shareholders (at least here at Agora) want a change now because they want the shareprice to increase now because they want to sell then

But with a newly recertified '336 the price should increase anyway, no matter who is on the BoD. Simply changing one BoD member isn't going to speed up licensing, which will underpin any price increase.

I have a "target price" but if I see further potential when that price is reached, I may still hold at least some to benefit from any additional increases over and above that target.

.

.

.

Be well

Share
New Message
Please login to post a reply